L'AQUILA, Italy, July 12, 2019(Newswire.com) - Dante Labstoday introduced a new artificial intelligence (AI) tool to create personalized reports from whole genome sequencing data that leverages a person's medical information to identify the most relevant insights across the six billion letters that make up human DNA. Dante Labs' use of AI is a completely new approach to the interpretation of genetic data. The old approach was to analyze only small sections of the DNA--the so-called target panels--or to simply provide unfiltered raw data because companies lacked the computational power and capabilities to analyze the entire DNA. The use of AI is particularly valuable for complex conditions such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. 'The old approach was to give up on the power of the whole genome,' said Andrea Riposati, CEO of Dante Labs.